<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02298179</url>
  </required_header>
  <id_info>
    <org_study_id>205219</org_study_id>
    <secondary_id>2014-000145-69</secondary_id>
    <secondary_id>V122_01</secondary_id>
    <nct_id>NCT02298179</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults</brief_title>
  <official_title>A Phase 1 Randomized, Observer Blind, Placebo Controlled, Dosage-Escalation Single Center Study to Evaluate the Safety and Immunogenicity of an RSV Fusion Glycoprotein (F) Subunit Vaccine in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and immunogenicity of two doses of the
      investigational RSV F subunit vaccine administered intramuscularly (IM). In this current
      Phase 1, first-in-human study, the three different antigen amounts that have been selected
      will be evaluated in a stepwise manner in three different cohorts (Cohort 1: low dosage of
      RSV F subunit vaccine, Cohort 2: middle dosage of RSV F subunit vaccine, and Cohort 3: high
      dosage of RSV F subunit vaccine). In addition, the effect of an adjuvant, either aluminum
      hydroxide or MF59, and antibody kinetics post-vaccination at different time points will be
      evaluated as compared to unadjuvanted RSV F subunit vaccine at the same dosage levels.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 19, 2014</start_date>
  <completion_date type="Actual">March 27, 2017</completion_date>
  <primary_completion_date type="Actual">March 27, 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Geometric Mean Titers (GMTs) of the Serum Anti-RSV Neutralizing Antibody (NAb) Titers</measure>
    <time_frame>At Day 57</time_frame>
    <description>Immunogenicity was measured in terms of the Geometric mean titers (GMTs) of the serum anti-RSV neutralizing antibody (NAb) titers at Day 57 (28 days after the second dose).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Subjects With a ≥ 4-fold Increase in Serum Anti-RSV NAb Titers</measure>
    <time_frame>At Day 57</time_frame>
    <description>Immunogenicity was measured in terms of percentage of subjects with a ≥ 4-fold increase in serum anti-RSV NAb titers, from Day 1 (baseline) to Day 57 (28 days after the second dose).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Any Solicited Local Symptoms</measure>
    <time_frame>Within 30 minutes after each vaccination</time_frame>
    <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Any Solicited Local Symptoms</measure>
    <time_frame>From Day 1 (6 hour) through Day 3 after each vaccination</time_frame>
    <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Any Solicited Local Symptoms</measure>
    <time_frame>From Day 4 through Day 7 after each vaccination</time_frame>
    <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Any Solicited Local Symptoms</measure>
    <time_frame>From Day 1 (6 hours) to Day 7 after each vaccination</time_frame>
    <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</measure>
    <time_frame>Within 30 minutes after each vaccination</time_frame>
    <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</measure>
    <time_frame>From Day 1 (6 hours) through Day 3 after each vaccination</time_frame>
    <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</measure>
    <time_frame>From Day 4 through Day 7 after each vaccination</time_frame>
    <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</measure>
    <time_frame>From Day 1 (6 hours) to Day 7 after each vaccination</time_frame>
    <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Unsolicited Adverse Events (AEs)</measure>
    <time_frame>From Day 1 to Day 28 after each vaccination</time_frame>
    <description>An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms.
Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Serious Adverse Events (SAEs) and Other Significant AE(s)</measure>
    <time_frame>From study start (Day 1) until study completion (Day 394)</time_frame>
    <description>SAEs assessed include medical occurrences that resulted in death, were life-threatening, required hospitalization or prolongation of hospitalization or resulted in disability/incapacity, congenital anomaly or birth defect. Any SAE = occurrence of the SAE regardless of intensity grade. Possibly or probably related SAE = SAE assessed by the investigator as possibly or probably related to the study vaccination.
Other significant AE(s) assessed include unsolicited medically attended AEs, unsolicited AEs leading to study withdrawal, new onset of chronic diseases (NOCDs) and adverse events of special interest (AESIs). Medically attended AE = an adverse event that leads to an unscheduled visit to a healthcare practitioner. NOCD = an adverse event that represents a new diagnosis of a chronic medical condition that was not present or suspected in a subject prior to study enrollment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titers (GMTs) of the Serum Anti-RSV Neutralizing Antibody (NAb) Titers</measure>
    <time_frame>At Day 1, Day 29 and Day 181</time_frame>
    <description>Immunogenicity was measured in terms of GMTs of the serum anti-RSV neutralizing antibody (NAb) titers at Day 1, Day 29 (28 days after the first dose) and Day 181 (six months after the first dose).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With a ≥ 4-fold Increase in Serum Anti-RSV NAb Titer</measure>
    <time_frame>At Day 29 and at Day 181</time_frame>
    <description>Immunogenicity was measured in terms of percentage of subjects with a ≥ 4-fold increase in serum anti-RSV NAb titers from Day 1 to Day 29 (28 days after the first dose) and from Day 1 to Day 181 (six months after the first dose).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With Serum Anti-RSV NAb Titers Greater Than the 3rd Quartile of Serum Anti-RSV NAb Titers at Day 1</measure>
    <time_frame>At Day 29, Day 57 and Day 181</time_frame>
    <description>Immunogenicity was measured in terms of the percentage of subjects at Day 29 (28 days after the first dose), Day 57 (28 days after the second dose) and Day 181 (six months after the first dose) with serum anti-RSV NAb titers greater than the 3rd quartile of serum anti-RSV NAb titers at Day 1 (baseline).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titers (GMTs) of the Serum Total Binding Antibody to Each of the RSV Proteins F, G and N</measure>
    <time_frame>At Day 1, Day 29, Day 57 and Day 181</time_frame>
    <description>Immunogenicity was measured in terms of the geometric mean titers (GMTs) of the serum total binding antibody to each of the RSV proteins F, G and N at Day 1 (baseline), Day 29 (28 days after the first dose), Day 57 (28 days after the second dose) and Day 181 (six months after the first dose).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With a ≥ 4-fold Increase in Serum Total Binding Antibody to Each of the RSV Proteins F, G and N</measure>
    <time_frame>At Day 29, Day 57 and Day 181</time_frame>
    <description>Immunogenicity was measured in terms of the percentage of subjects with a ≥ 4-fold increase in serum total binding antibody to each of the RSV Proteins F, G and N from Day 1 (baseline) to all time points (Day 29 [28 days after the first dose], Day 57 [28 days after the second dose], and Day 181 [six months after the first dose]).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With Serum Total Binding Antibody Titers to Each of the RSV Proteins F, G, and N Greater Than the 3rd Quartile of Serum Total Binding Antibody Titers to RSV Protein F at Day 1</measure>
    <time_frame>At Day 29, Day 57 and Day 181</time_frame>
    <description>Immunogenicity was measured in terms of the percentage of subjects at Day 29 (28 days after the first dose), Day 57 (28 days after the second dose) and Day 181 (six months after the first dose), with serum total binding antibody titers to each of the RSV proteins F, G, and N greater than the 3rd quartile of serum total binding antibody titers to RSV protein F at Day 1 (baseline).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of RSV F Serum Nab Titers to Each of the RSV F Serum Total Binding Antibody Titers to RSV Proteins F, G and N</measure>
    <time_frame>At Day 1, Day 29, Day 57 and Day 181</time_frame>
    <description>Immunogenicity was measured in terms of the ratio of RSV F serum Nab titers to each of the RSV F serum total binding antibody titers to RSV proteins F, G and N at Days 1, 29, 57 and 181.</description>
  </secondary_outcome>
  <number_of_arms>12</number_of_arms>
  <enrollment type="Actual">288</enrollment>
  <condition>Respiratory Syncytial Virus (RSV)</condition>
  <arm_group>
    <arm_group_label>RSV F 45 No Adj Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSV F 45 Alum Adj Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSV F 45 MF59 Adj Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo 1 Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSV F 90 No Adj Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSV F 90 Alum Adj Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSV F 90 MF59 Adj Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo 2 Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSV F 135 No Adj Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSV F 135 Alum Adj Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSV F 135 MF59 Adj Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo 3 Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RSV F subunit 45 μg No adjuvant</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>RSV F 45 No Adj Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RSV F subunit 45 μg Aluminum hydroxide adjuvant</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>RSV F 45 Alum Adj Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RSV F subunit 45 μg MF59 adjuvant</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>RSV F 45 MF59 Adj Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RSV F subunit 90 μg No adjuvant</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>RSV F 90 No Adj Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RSV F subunit 90 μg Aluminum hydroxide adjuvant</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>RSV F 90 Alum Adj Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RSV F subunit 90 μg MF59 adjuvant</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>RSV F 90 MF59 Adj Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RSV F subunit 135 μg No adjuvant</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>RSV F 135 No Adj Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RSV F subunit 135 μg Aluminum hydroxide adjuvant</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>RSV F 135 Alum Adj Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RSV F subunit 135 μg MF59 adjuvant</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>RSV F 135 MF59 Adj Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>2 doses of 0.5 milliliters (mL) each of injectable solution administered intramuscularly, in the deltoid muscle, preferably in the non-dominant arm.</description>
    <arm_group_label>Placebo 1 Group</arm_group_label>
    <arm_group_label>Placebo 2 Group</arm_group_label>
    <arm_group_label>Placebo 3 Group</arm_group_label>
    <other_name>Sterile saline 0.9%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy males and non-pregnant females 18 to 45 years of age at time of enrollment.

          2. Individuals who have given written consent after the nature of the study has been
             explained according to local regulatory requirements.

          3. Individuals in good health as determined by the outcome of the medical history,
             physical examination and clinical judgment of the investigator.

          4. Individuals who can comply with the study procedures and are available for follow up.

        Exclusion Criteria:

          1. Individuals with any severe chronic or acute disease.

          2. Individuals with a history of illness or with an ongoing illness that may pose
             additional risk to the subject if he/she participates in the study, including the
             following:

               -  History of any chronic respiratory illness, including current diagnosis of asthma
                  within 2 years, exercise induced wheezing, reactive airway disease, emphysema,
                  chronic bronchitis, cystic fibrosis or chronic obstructive pulmonary disease
                  (COPD).

               -  Any respiratory illness within 7 days prior to receiving the first study
                  injection.

               -  Any active pulmonary infection or other inflammatory conditions, even in the
                  absence of febrile episodes, within 14 days prior to the first study injection.

               -  Hepatitis B or hepatitis C infection.

          3. Individuals who have had a malignancy or lymphoproliferative disorder within the past
             5 years.

          4. Individuals with known or suspected impairment of the immune system including but not
             limited to HIV, autoimmune disorders, immunosuppressive therapy, and diabetes
             mellitus.

          5. Individuals with any history of progressive or severe neurologic disorder, seizure
             disorder or Guillian-Barré syndrome.

          6. Individuals with a known bleeding diathesis, or any condition that may be associated
             with a prolonged bleeding time.

          7. Individuals with a BMI &gt; 35 kg/m2. BMI is to be calculated by the following formula:
             subject weight at baseline divided by subject height in meters multiplied by the
             subject height in meters. The numerical result will be rounded to the nearest 0.1.

          8. Individuals who are allergic to any of the vaccine components, or with a history of
             anaphylaxis after vaccination.

          9. Individuals who during the 90 days prior to enrollment receive any medications or
             other treatments that may adversely affect the immune system such as allergy
             injections, immune globulin, interferon, immunomodulators, cytotoxic drugs or other
             drugs known to be frequently associated with significant major organ toxicity.

         10. Individuals who receive systemic immunosuppressive agents including steroids. Prior
             corticosteroid therapy should be discontinued 28 days prior to enrollment. Individuals
             using inhaled or topical corticosteroids will be permitted.

         11. Receipt or donation of blood or blood products 8 weeks prior to vaccination or planned
             receipt or donation during the study period.

         12. Individuals participating in any clinical trial with another investigational product
             28 days prior to receiving the first study vaccination or intent to participate in
             another clinical study at any time during the conduct of this study.

         13. Individuals who have received any vaccine 28 days prior to enrollment in this study,
             or who plan to receive any non-study vaccines within 28 days of the second dose of
             study vaccine.

         14. Individuals with any clinically significant abnormal safety laboratory result, as
             judged by the investigator.

         15. If female, 'of childbearing potential', sexually active and has not used any of the
             'acceptable contraceptive methods' for at least two months prior to study entry.

             Childbearing potential is defined as status post onset of menarche and not meeting any
             of the following conditions: menopausal for at least two years; sterile status after
             bilateral tubal ligation for at least one year, immediately after bilateral
             oophorectomy or after hysterectomy.

             Acceptable methods of birth control are defined as one or more of the following:

               -  Hormonal contraceptives.

               -  Barrier each and every time during intercourse.

               -  Intrauterine device (IUD).

               -  Monogamous relationship with vasectomized partner. Partner must have been
                  vasectomized for at least six months prior to subject's study entry.

         16. If female subject of childbearing potential and have a positive urine pregnancy test
             prior to study vaccinations, or are currently lactating.

         17. If female of childbearing potential and sexually active, refusal to use an 'acceptable
             contraceptive method' through to three weeks after last study vaccination.

         18. Individuals with behavioral or cognitive impairment or psychiatric disease that, in
             the opinion of the investigator, may interfere with the subject's ability to
             participate in the study.

         19. Individuals with a history of drug or alcohol abuse within the past 2 years.

         20. Individuals who are acting as study personnel or immediate family members or the
             spouse of study personnel.

         21. Individuals with a body temperature ≥38 °C (≥100.4◦F) within 3 days of intended study
             vaccination.

         22. Individuals with any condition that, in the opinion of the investigator, would
             interfere with the primary study objectives.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>November 19, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2014</study_first_posted>
  <results_first_submitted>March 26, 2018</results_first_submitted>
  <results_first_submitted_qc>August 10, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 13, 2018</results_first_posted>
  <last_update_submitted>August 10, 2018</last_update_submitted>
  <last_update_submitted_qc>August 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Antibodies</keyword>
  <keyword>Respiratory syncytial virus</keyword>
  <keyword>Safety</keyword>
  <keyword>Healthy adults</keyword>
  <keyword>Immunogenicity</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aluminum Hydroxide</mesh_term>
    <mesh_term>MF59 oil emulsion</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 12, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT02298179/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 18, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT02298179/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were enrolled from one site in Belgium.</recruitment_details>
      <pre_assignment_details>All subjects enrolled were included in the trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>RSV F 45 No Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
        </group>
        <group group_id="P2">
          <title>RSV F 45 Alum Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
        </group>
        <group group_id="P3">
          <title>RSV F 45 MF59 Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
        </group>
        <group group_id="P4">
          <title>Placebo 1 Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
        </group>
        <group group_id="P5">
          <title>RSV F 90 No Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
        </group>
        <group group_id="P6">
          <title>RSV F 90 Alum Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
        </group>
        <group group_id="P7">
          <title>RSV F 90 MF59 Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
        </group>
        <group group_id="P8">
          <title>Placebo 2 Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
        </group>
        <group group_id="P9">
          <title>RSV F 135 No Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
        </group>
        <group group_id="P10">
          <title>RSV F 135 Alum Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
        </group>
        <group group_id="P11">
          <title>RSV F 135 MF59 Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
        </group>
        <group group_id="P12">
          <title>Placebo 3 Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="24"/>
                <participants group_id="P4" count="24"/>
                <participants group_id="P5" count="24"/>
                <participants group_id="P6" count="24"/>
                <participants group_id="P7" count="24"/>
                <participants group_id="P8" count="24"/>
                <participants group_id="P9" count="24"/>
                <participants group_id="P10" count="24"/>
                <participants group_id="P11" count="24"/>
                <participants group_id="P12" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="24"/>
                <participants group_id="P5" count="24"/>
                <participants group_id="P6" count="24"/>
                <participants group_id="P7" count="24"/>
                <participants group_id="P8" count="23"/>
                <participants group_id="P9" count="24"/>
                <participants group_id="P10" count="24"/>
                <participants group_id="P11" count="24"/>
                <participants group_id="P12" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>RSV F 45 No Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
        </group>
        <group group_id="B2">
          <title>RSV F 45 Alum Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
        </group>
        <group group_id="B3">
          <title>RSV F 45 MF59 Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
        </group>
        <group group_id="B4">
          <title>Placebo 1 Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
        </group>
        <group group_id="B5">
          <title>RSV F 90 No Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
        </group>
        <group group_id="B6">
          <title>RSV F 90 Alum Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
        </group>
        <group group_id="B7">
          <title>RSV F 90 MF59 Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
        </group>
        <group group_id="B8">
          <title>Placebo 2 Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
        </group>
        <group group_id="B9">
          <title>RSV F 135 No Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
        </group>
        <group group_id="B10">
          <title>RSV F 135 Alum Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
        </group>
        <group group_id="B11">
          <title>RSV F 135 MF59 Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
        </group>
        <group group_id="B12">
          <title>Placebo 3 Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
        </group>
        <group group_id="B13">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="24"/>
            <count group_id="B4" value="24"/>
            <count group_id="B5" value="24"/>
            <count group_id="B6" value="24"/>
            <count group_id="B7" value="24"/>
            <count group_id="B8" value="24"/>
            <count group_id="B9" value="24"/>
            <count group_id="B10" value="24"/>
            <count group_id="B11" value="24"/>
            <count group_id="B12" value="24"/>
            <count group_id="B13" value="288"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.6" spread="6.8"/>
                    <measurement group_id="B2" value="27.7" spread="6.55"/>
                    <measurement group_id="B3" value="30.2" spread="7.9"/>
                    <measurement group_id="B4" value="30.3" spread="7.62"/>
                    <measurement group_id="B5" value="30.4" spread="8.31"/>
                    <measurement group_id="B6" value="31.2" spread="7.47"/>
                    <measurement group_id="B7" value="27.6" spread="6.84"/>
                    <measurement group_id="B8" value="28" spread="7.3"/>
                    <measurement group_id="B9" value="28.3" spread="6.8"/>
                    <measurement group_id="B10" value="29.5" spread="6.98"/>
                    <measurement group_id="B11" value="32.9" spread="8.46"/>
                    <measurement group_id="B12" value="27.9" spread="5.86"/>
                    <measurement group_id="B13" value="29.13" spread="7.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="16"/>
                    <measurement group_id="B6" value="18"/>
                    <measurement group_id="B7" value="15"/>
                    <measurement group_id="B8" value="14"/>
                    <measurement group_id="B9" value="22"/>
                    <measurement group_id="B10" value="18"/>
                    <measurement group_id="B11" value="20"/>
                    <measurement group_id="B12" value="20"/>
                    <measurement group_id="B13" value="216"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="10"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="6"/>
                    <measurement group_id="B11" value="4"/>
                    <measurement group_id="B12" value="4"/>
                    <measurement group_id="B13" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>BLACK OR AFRICAN AMERICAN</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>WHITE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="24"/>
                    <measurement group_id="B5" value="24"/>
                    <measurement group_id="B6" value="24"/>
                    <measurement group_id="B7" value="24"/>
                    <measurement group_id="B8" value="23"/>
                    <measurement group_id="B9" value="24"/>
                    <measurement group_id="B10" value="24"/>
                    <measurement group_id="B11" value="24"/>
                    <measurement group_id="B12" value="24"/>
                    <measurement group_id="B13" value="284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NOT SPECIFIED</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Geometric Mean Titers (GMTs) of the Serum Anti-RSV Neutralizing Antibody (NAb) Titers</title>
        <description>Immunogenicity was measured in terms of the Geometric mean titers (GMTs) of the serum anti-RSV neutralizing antibody (NAb) titers at Day 57 (28 days after the second dose).</description>
        <time_frame>At Day 57</time_frame>
        <population>The analysis was based on the Per-Protocol Set (PPS), which included all subjects in the Full Analysis Set (FAS) Immunogenicity population who were not excluded due to the reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 57.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titers (GMTs) of the Serum Anti-RSV Neutralizing Antibody (NAb) Titers</title>
          <description>Immunogenicity was measured in terms of the Geometric mean titers (GMTs) of the serum anti-RSV neutralizing antibody (NAb) titers at Day 57 (28 days after the second dose).</description>
          <population>The analysis was based on the Per-Protocol Set (PPS), which included all subjects in the Full Analysis Set (FAS) Immunogenicity population who were not excluded due to the reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 57.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="23"/>
                <count group_id="O9" value="23"/>
                <count group_id="O10" value="22"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="864" lower_limit="692" upper_limit="1077"/>
                    <measurement group_id="O2" value="914" lower_limit="738" upper_limit="1134"/>
                    <measurement group_id="O3" value="843" lower_limit="673" upper_limit="1057"/>
                    <measurement group_id="O4" value="234" lower_limit="169" upper_limit="324"/>
                    <measurement group_id="O5" value="844" lower_limit="665" upper_limit="1072"/>
                    <measurement group_id="O6" value="746" lower_limit="587" upper_limit="947"/>
                    <measurement group_id="O7" value="944" lower_limit="735" upper_limit="1213"/>
                    <measurement group_id="O8" value="253" lower_limit="189" upper_limit="337"/>
                    <measurement group_id="O9" value="903" lower_limit="729" upper_limit="1119"/>
                    <measurement group_id="O10" value="1212" lower_limit="974" upper_limit="1509"/>
                    <measurement group_id="O11" value="1316" lower_limit="1066" upper_limit="1623"/>
                    <measurement group_id="O12" value="254" lower_limit="183" upper_limit="354"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects With a ≥ 4-fold Increase in Serum Anti-RSV NAb Titers</title>
        <description>Immunogenicity was measured in terms of percentage of subjects with a ≥ 4-fold increase in serum anti-RSV NAb titers, from Day 1 (baseline) to Day 57 (28 days after the second dose).</description>
        <time_frame>At Day 57</time_frame>
        <population>The analysis was based on PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and and for whom immunogenicity results collected from Day 1 (baseline) up to Day 57 were available at Day 1 and Day 57.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With a ≥ 4-fold Increase in Serum Anti-RSV NAb Titers</title>
          <description>Immunogenicity was measured in terms of percentage of subjects with a ≥ 4-fold increase in serum anti-RSV NAb titers, from Day 1 (baseline) to Day 57 (28 days after the second dose).</description>
          <population>The analysis was based on PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and and for whom immunogenicity results collected from Day 1 (baseline) up to Day 57 were available at Day 1 and Day 57.</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="23"/>
                <count group_id="O9" value="23"/>
                <count group_id="O10" value="22"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" lower_limit="24.4" upper_limit="67.8"/>
                    <measurement group_id="O2" value="54" lower_limit="32.8" upper_limit="74.4"/>
                    <measurement group_id="O3" value="36" lower_limit="17.2" upper_limit="59.3"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O6" value="29" lower_limit="12.6" upper_limit="51.1"/>
                    <measurement group_id="O7" value="41" lower_limit="20.7" upper_limit="63.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="17" lower_limit="5.0" upper_limit="38.8"/>
                    <measurement group_id="O10" value="45" lower_limit="24.4" upper_limit="67.8"/>
                    <measurement group_id="O11" value="46" lower_limit="25.6" upper_limit="67.2"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Any Solicited Local Symptoms</title>
        <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
        <time_frame>Within 30 minutes after each vaccination</time_frame>
        <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Any Solicited Local Symptoms</title>
          <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
          <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Induration (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Swelling (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Induration (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Swelling (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Any Solicited Local Symptoms</title>
        <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
        <time_frame>From Day 1 (6 hour) through Day 3 after each vaccination</time_frame>
        <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Any Solicited Local Symptoms</title>
          <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
          <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Induration (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Swelling (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="18"/>
                    <measurement group_id="O7" value="20"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="12"/>
                    <measurement group_id="O10" value="22"/>
                    <measurement group_id="O11" value="18"/>
                    <measurement group_id="O12" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Induration (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Swelling (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="11"/>
                    <measurement group_id="O11" value="14"/>
                    <measurement group_id="O12" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Any Solicited Local Symptoms</title>
        <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
        <time_frame>From Day 4 through Day 7 after each vaccination</time_frame>
        <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Any Solicited Local Symptoms</title>
          <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
          <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Induration (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Swelling (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="9"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Induration (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Swelling (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Any Solicited Local Symptoms</title>
        <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
        <time_frame>From Day 1 (6 hours) to Day 7 after each vaccination</time_frame>
        <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Any Solicited Local Symptoms</title>
          <description>Assessed solicited local symptoms were: induration, swelling, erythema and pain. Any induration/swelling/erythema = induration/swelling/erythema spreading beyond 25 millimeters (mm) of injection site. Any pain = occurrence of the symptom regardless of intensity grade.</description>
          <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Induration (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Swelling (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="18"/>
                    <measurement group_id="O7" value="20"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="13"/>
                    <measurement group_id="O10" value="22"/>
                    <measurement group_id="O11" value="18"/>
                    <measurement group_id="O12" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Induration (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Swelling (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Erythema (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Pain (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="11"/>
                    <measurement group_id="O11" value="14"/>
                    <measurement group_id="O12" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</title>
        <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
        <time_frame>Within 30 minutes after each vaccination</time_frame>
        <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</title>
          <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
          <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Nausea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fever (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Coughing (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Diarrhea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Rhinorrhea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Wheezing (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fever (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Coughing (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Diarrhea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Rhinorrhea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Wheezing (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</title>
        <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
        <time_frame>From Day 1 (6 hours) through Day 3 after each vaccination</time_frame>
        <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</title>
          <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
          <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Nausea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="7"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="7"/>
                    <measurement group_id="O12" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="9"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fever (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Coughing (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Diarrhea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Rhinorrhea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="8"/>
                    <measurement group_id="O11" value="6"/>
                    <measurement group_id="O12" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Wheezing (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="6"/>
                    <measurement group_id="O12" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fever (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Coughing (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Diarrhea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Rhinorrhea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Wheezing (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="23"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="23"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</title>
        <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
        <time_frame>From Day 4 through Day 7 after each vaccination</time_frame>
        <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</title>
          <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
          <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Nausea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="7"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="7"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fever (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Coughing (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Diarrhea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Rhinorrhea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="9"/>
                    <measurement group_id="O12" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Wheezing (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fever (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Coughing (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Diarrhea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Rhinorrhea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Wheezing (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="23"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="23"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</title>
        <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
        <time_frame>From Day 1 (6 hours) to Day 7 after each vaccination</time_frame>
        <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Any Solicited Systemic Symptoms and Other Indicators of Reactogenicity</title>
          <description>Assessed solicited systemic symptoms were: nausea, fatigue, myalgia, arthralgia, headache, fever (body temperature ≥ 38.0°C), chills, coughing, diarrhea, rhinorrhea and wheezing. Other solicited data included: prevention of pain and/or fever and treatment of pain and/or fever. Any = occurrence of the symptom regardless of intensity grade.</description>
          <population>The analysis was based on the Solicited Safety set, which included all subjects in the Exposed population who provided post-vaccination reactogenicity data after each vaccination.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any Nausea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="5"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="8"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="9"/>
                    <measurement group_id="O12" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="9"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="9"/>
                    <measurement group_id="O11" value="10"/>
                    <measurement group_id="O12" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fever (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Coughing (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="6"/>
                    <measurement group_id="O12" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Diarrhea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Rhinorrhea (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="10"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="9"/>
                    <measurement group_id="O11" value="10"/>
                    <measurement group_id="O12" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Wheezing (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment (1st)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Nausea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fatigue (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="8"/>
                    <measurement group_id="O12" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Myalgia (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Arthralgia (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Headache (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="6"/>
                    <measurement group_id="O12" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Fever (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Chills (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Coughing (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Diarrhea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Rhinorrhea (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="6"/>
                    <measurement group_id="O12" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Wheezing (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever prevention (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="23"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Fever treatment (2nd)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="23"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Unsolicited Adverse Events (AEs)</title>
        <description>An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms.
Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination.</description>
        <time_frame>From Day 1 to Day 28 after each vaccination</time_frame>
        <population>The analysis was based on the Unsolicited Safety Set, which included all subjects in the Exposed population with unsolicited AE data collected after each vaccination.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Unsolicited Adverse Events (AEs)</title>
          <description>An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms.
Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination.</description>
          <population>The analysis was based on the Unsolicited Safety Set, which included all subjects in the Exposed population with unsolicited AE data collected after each vaccination.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any AE(s) (1st vacc.)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="24"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="24"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="14"/>
                    <measurement group_id="O9" value="13"/>
                    <measurement group_id="O10" value="14"/>
                    <measurement group_id="O11" value="15"/>
                    <measurement group_id="O12" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any AE(s) (2nd vacc.)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="24"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="24"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="13"/>
                    <measurement group_id="O9" value="10"/>
                    <measurement group_id="O10" value="9"/>
                    <measurement group_id="O11" value="13"/>
                    <measurement group_id="O12" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Serious Adverse Events (SAEs) and Other Significant AE(s)</title>
        <description>SAEs assessed include medical occurrences that resulted in death, were life-threatening, required hospitalization or prolongation of hospitalization or resulted in disability/incapacity, congenital anomaly or birth defect. Any SAE = occurrence of the SAE regardless of intensity grade. Possibly or probably related SAE = SAE assessed by the investigator as possibly or probably related to the study vaccination.
Other significant AE(s) assessed include unsolicited medically attended AEs, unsolicited AEs leading to study withdrawal, new onset of chronic diseases (NOCDs) and adverse events of special interest (AESIs). Medically attended AE = an adverse event that leads to an unscheduled visit to a healthcare practitioner. NOCD = an adverse event that represents a new diagnosis of a chronic medical condition that was not present or suspected in a subject prior to study enrollment.</description>
        <time_frame>From study start (Day 1) until study completion (Day 394)</time_frame>
        <population>The analysis was based on the Unsolicited Safety Set, which included all subjects in the Exposed population with unsolicited AE data collected from study start (Day 1) until study completion (Day 394).</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Serious Adverse Events (SAEs) and Other Significant AE(s)</title>
          <description>SAEs assessed include medical occurrences that resulted in death, were life-threatening, required hospitalization or prolongation of hospitalization or resulted in disability/incapacity, congenital anomaly or birth defect. Any SAE = occurrence of the SAE regardless of intensity grade. Possibly or probably related SAE = SAE assessed by the investigator as possibly or probably related to the study vaccination.
Other significant AE(s) assessed include unsolicited medically attended AEs, unsolicited AEs leading to study withdrawal, new onset of chronic diseases (NOCDs) and adverse events of special interest (AESIs). Medically attended AE = an adverse event that leads to an unscheduled visit to a healthcare practitioner. NOCD = an adverse event that represents a new diagnosis of a chronic medical condition that was not present or suspected in a subject prior to study enrollment.</description>
          <population>The analysis was based on the Unsolicited Safety Set, which included all subjects in the Exposed population with unsolicited AE data collected from study start (Day 1) until study completion (Day 394).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="24"/>
                <count group_id="O10" value="24"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any SAE(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Possibly/probably related SAE(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any medically attended AE(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="15"/>
                    <measurement group_id="O10" value="15"/>
                    <measurement group_id="O11" value="12"/>
                    <measurement group_id="O12" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any AE(s) leading to study withdrawal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any NOCD(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any AESI(s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titers (GMTs) of the Serum Anti-RSV Neutralizing Antibody (NAb) Titers</title>
        <description>Immunogenicity was measured in terms of GMTs of the serum anti-RSV neutralizing antibody (NAb) titers at Day 1, Day 29 (28 days after the first dose) and Day 181 (six months after the first dose).</description>
        <time_frame>At Day 1, Day 29 and Day 181</time_frame>
        <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29 and at Day 181.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titers (GMTs) of the Serum Anti-RSV Neutralizing Antibody (NAb) Titers</title>
          <description>Immunogenicity was measured in terms of GMTs of the serum anti-RSV neutralizing antibody (NAb) titers at Day 1, Day 29 (28 days after the first dose) and Day 181 (six months after the first dose).</description>
          <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29 and at Day 181.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="23"/>
                <count group_id="O10" value="23"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Anti-RSV NAb, Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="237" lower_limit="162" upper_limit="345"/>
                    <measurement group_id="O2" value="184" lower_limit="127" upper_limit="266"/>
                    <measurement group_id="O3" value="340" lower_limit="233" upper_limit="497"/>
                    <measurement group_id="O4" value="215" lower_limit="155" upper_limit="298"/>
                    <measurement group_id="O5" value="289" lower_limit="209" upper_limit="399"/>
                    <measurement group_id="O6" value="280" lower_limit="203" upper_limit="387"/>
                    <measurement group_id="O7" value="254" lower_limit="181" upper_limit="356"/>
                    <measurement group_id="O8" value="233" lower_limit="175" upper_limit="308"/>
                    <measurement group_id="O9" value="338" lower_limit="240" upper_limit="476"/>
                    <measurement group_id="O10" value="332" lower_limit="236" upper_limit="467"/>
                    <measurement group_id="O11" value="380" lower_limit="272" upper_limit="531"/>
                    <measurement group_id="O12" value="292" lower_limit="217" upper_limit="392"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anti-RSV NAb, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="893" lower_limit="702" upper_limit="1136"/>
                    <measurement group_id="O2" value="947" lower_limit="745" upper_limit="1203"/>
                    <measurement group_id="O3" value="983" lower_limit="769" upper_limit="1257"/>
                    <measurement group_id="O4" value="236" lower_limit="171" upper_limit="326"/>
                    <measurement group_id="O5" value="1110" lower_limit="869" upper_limit="1419"/>
                    <measurement group_id="O6" value="981" lower_limit="768" upper_limit="1253"/>
                    <measurement group_id="O7" value="1208" lower_limit="935" upper_limit="1561"/>
                    <measurement group_id="O8" value="242" lower_limit="188" upper_limit="313"/>
                    <measurement group_id="O9" value="1123" lower_limit="872" upper_limit="1447"/>
                    <measurement group_id="O10" value="1602" lower_limit="1243" upper_limit="2064"/>
                    <measurement group_id="O11" value="1551" lower_limit="1210" upper_limit="1988"/>
                    <measurement group_id="O12" value="286" lower_limit="218" upper_limit="374"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anti-RSV NAb, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="576" lower_limit="463" upper_limit="717"/>
                    <measurement group_id="O2" value="587" lower_limit="474" upper_limit="726"/>
                    <measurement group_id="O3" value="450" lower_limit="360" upper_limit="563"/>
                    <measurement group_id="O4" value="234" lower_limit="166" upper_limit="328"/>
                    <measurement group_id="O5" value="684" lower_limit="558" upper_limit="840"/>
                    <measurement group_id="O6" value="627" lower_limit="508" upper_limit="774"/>
                    <measurement group_id="O7" value="597" lower_limit="478" upper_limit="745"/>
                    <measurement group_id="O8" value="260" lower_limit="202" upper_limit="335"/>
                    <measurement group_id="O9" value="687" lower_limit="566" upper_limit="834"/>
                    <measurement group_id="O10" value="788" lower_limit="649" upper_limit="957"/>
                    <measurement group_id="O11" value="764" lower_limit="632" upper_limit="923"/>
                    <measurement group_id="O12" value="248" lower_limit="191" upper_limit="321"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With a ≥ 4-fold Increase in Serum Anti-RSV NAb Titer</title>
        <description>Immunogenicity was measured in terms of percentage of subjects with a ≥ 4-fold increase in serum anti-RSV NAb titers from Day 1 to Day 29 (28 days after the first dose) and from Day 1 to Day 181 (six months after the first dose).</description>
        <time_frame>At Day 29 and at Day 181</time_frame>
        <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29 and Day 181.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With a ≥ 4-fold Increase in Serum Anti-RSV NAb Titer</title>
          <description>Immunogenicity was measured in terms of percentage of subjects with a ≥ 4-fold increase in serum anti-RSV NAb titers from Day 1 to Day 29 (28 days after the first dose) and from Day 1 to Day 181 (six months after the first dose).</description>
          <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29 and Day 181.</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="23"/>
                <count group_id="O10" value="23"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Anti-RSV NAb, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" lower_limit="26.8" upper_limit="69.4"/>
                    <measurement group_id="O2" value="58" lower_limit="36.6" upper_limit="77.9"/>
                    <measurement group_id="O3" value="30" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O6" value="42" lower_limit="22.1" upper_limit="63.4"/>
                    <measurement group_id="O7" value="50" lower_limit="28.2" upper_limit="71.8"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O9" value="35" lower_limit="16.4" upper_limit="57.3"/>
                    <measurement group_id="O10" value="57" lower_limit="34.5" upper_limit="76.8"/>
                    <measurement group_id="O11" value="42" lower_limit="22.1" upper_limit="63.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anti-RSV NAb, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32" lower_limit="13.9" upper_limit="54.9"/>
                    <measurement group_id="O2" value="29" lower_limit="12.6" upper_limit="51.1"/>
                    <measurement group_id="O3" value="5" lower_limit="0.12" upper_limit="22.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O5" value="17" lower_limit="5.0" upper_limit="38.8"/>
                    <measurement group_id="O6" value="14" lower_limit="2.9" upper_limit="34.9"/>
                    <measurement group_id="O7" value="15" lower_limit="3.2" upper_limit="37.9"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="14" lower_limit="2.9" upper_limit="34.9"/>
                    <measurement group_id="O10" value="27" lower_limit="10.7" upper_limit="50.2"/>
                    <measurement group_id="O11" value="17" lower_limit="5.0" upper_limit="38.8"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With Serum Anti-RSV NAb Titers Greater Than the 3rd Quartile of Serum Anti-RSV NAb Titers at Day 1</title>
        <description>Immunogenicity was measured in terms of the percentage of subjects at Day 29 (28 days after the first dose), Day 57 (28 days after the second dose) and Day 181 (six months after the first dose) with serum anti-RSV NAb titers greater than the 3rd quartile of serum anti-RSV NAb titers at Day 1 (baseline).</description>
        <time_frame>At Day 29, Day 57 and Day 181</time_frame>
        <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Serum Anti-RSV NAb Titers Greater Than the 3rd Quartile of Serum Anti-RSV NAb Titers at Day 1</title>
          <description>Immunogenicity was measured in terms of the percentage of subjects at Day 29 (28 days after the first dose), Day 57 (28 days after the second dose) and Day 181 (six months after the first dose) with serum anti-RSV NAb titers greater than the 3rd quartile of serum anti-RSV NAb titers at Day 1 (baseline).</description>
          <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="23"/>
                <count group_id="O10" value="23"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Anti-RSV NAb, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78" lower_limit="56.3" upper_limit="92.5"/>
                    <measurement group_id="O2" value="83" lower_limit="62.6" upper_limit="95.3"/>
                    <measurement group_id="O3" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="17" lower_limit="5.0" upper_limit="38.8"/>
                    <measurement group_id="O5" value="92" lower_limit="73.0" upper_limit="99.0"/>
                    <measurement group_id="O6" value="92" lower_limit="73.0" upper_limit="99.0"/>
                    <measurement group_id="O7" value="91" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O8" value="13" lower_limit="2.7" upper_limit="32.4"/>
                    <measurement group_id="O9" value="91" lower_limit="72.0" upper_limit="98.9"/>
                    <measurement group_id="O10" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O11" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O12" value="25" lower_limit="9.8" upper_limit="46.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anti-RSV NAb, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="77.2" upper_limit="99.88"/>
                    <measurement group_id="O2" value="79" lower_limit="57.8" upper_limit="92.9"/>
                    <measurement group_id="O3" value="95" lower_limit="77.2" upper_limit="99.88"/>
                    <measurement group_id="O4" value="9" lower_limit="1.1" upper_limit="28.0"/>
                    <measurement group_id="O5" value="83" lower_limit="62.6" upper_limit="95.3"/>
                    <measurement group_id="O6" value="79" lower_limit="57.8" upper_limit="92.9"/>
                    <measurement group_id="O7" value="95" lower_limit="77.2" upper_limit="99.88"/>
                    <measurement group_id="O8" value="17" lower_limit="5.0" upper_limit="38.8"/>
                    <measurement group_id="O9" value="91" lower_limit="72.0" upper_limit="98.9"/>
                    <measurement group_id="O10" value="91" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O11" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O12" value="25" lower_limit="9.8" upper_limit="46.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anti-RSV NAb, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64" lower_limit="40.7" upper_limit="82.8"/>
                    <measurement group_id="O2" value="50" lower_limit="29.1" upper_limit="70.9"/>
                    <measurement group_id="O3" value="64" lower_limit="40.7" upper_limit="82.8"/>
                    <measurement group_id="O4" value="18" lower_limit="5.2" upper_limit="40.3"/>
                    <measurement group_id="O5" value="87" lower_limit="66.4" upper_limit="97.2"/>
                    <measurement group_id="O6" value="73" lower_limit="49.8" upper_limit="89.3"/>
                    <measurement group_id="O7" value="65" lower_limit="40.8" upper_limit="84.6"/>
                    <measurement group_id="O8" value="13" lower_limit="2.8" upper_limit="33.6"/>
                    <measurement group_id="O9" value="68" lower_limit="45.1" upper_limit="86.1"/>
                    <measurement group_id="O10" value="82" lower_limit="59.7" upper_limit="94.8"/>
                    <measurement group_id="O11" value="74" lower_limit="51.6" upper_limit="89.8"/>
                    <measurement group_id="O12" value="17" lower_limit="4.7" upper_limit="37.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titers (GMTs) of the Serum Total Binding Antibody to Each of the RSV Proteins F, G and N</title>
        <description>Immunogenicity was measured in terms of the geometric mean titers (GMTs) of the serum total binding antibody to each of the RSV proteins F, G and N at Day 1 (baseline), Day 29 (28 days after the first dose), Day 57 (28 days after the second dose) and Day 181 (six months after the first dose).</description>
        <time_frame>At Day 1, Day 29, Day 57 and Day 181</time_frame>
        <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titers (GMTs) of the Serum Total Binding Antibody to Each of the RSV Proteins F, G and N</title>
          <description>Immunogenicity was measured in terms of the geometric mean titers (GMTs) of the serum total binding antibody to each of the RSV proteins F, G and N at Day 1 (baseline), Day 29 (28 days after the first dose), Day 57 (28 days after the second dose) and Day 181 (six months after the first dose).</description>
          <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="23"/>
                <count group_id="O10" value="23"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>RSV Protein F, Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="671" lower_limit="470" upper_limit="958"/>
                    <measurement group_id="O2" value="838" lower_limit="591" upper_limit="1188"/>
                    <measurement group_id="O3" value="916" lower_limit="642" upper_limit="1309"/>
                    <measurement group_id="O4" value="714" lower_limit="530" upper_limit="961"/>
                    <measurement group_id="O5" value="697" lower_limit="483" upper_limit="1005"/>
                    <measurement group_id="O6" value="730" lower_limit="506" upper_limit="1053"/>
                    <measurement group_id="O7" value="751" lower_limit="512" upper_limit="1101"/>
                    <measurement group_id="O8" value="727" lower_limit="574" upper_limit="921"/>
                    <measurement group_id="O9" value="880" lower_limit="639" upper_limit="1210"/>
                    <measurement group_id="O10" value="685" lower_limit="498" upper_limit="942"/>
                    <measurement group_id="O11" value="910" lower_limit="666" upper_limit="1244"/>
                    <measurement group_id="O12" value="750" lower_limit="586" upper_limit="959"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9641" lower_limit="7964" upper_limit="11671"/>
                    <measurement group_id="O2" value="11131" lower_limit="9244" upper_limit="13403"/>
                    <measurement group_id="O3" value="11639" lower_limit="9620" upper_limit="14080"/>
                    <measurement group_id="O4" value="675" lower_limit="504" upper_limit="905"/>
                    <measurement group_id="O5" value="13017" lower_limit="11147" upper_limit="15201"/>
                    <measurement group_id="O6" value="10694" lower_limit="9158" upper_limit="12488"/>
                    <measurement group_id="O7" value="12841" lower_limit="10921" upper_limit="15099"/>
                    <measurement group_id="O8" value="684" lower_limit="515" upper_limit="909"/>
                    <measurement group_id="O9" value="13252" lower_limit="11607" upper_limit="15130"/>
                    <measurement group_id="O10" value="13514" lower_limit="11824" upper_limit="15446"/>
                    <measurement group_id="O11" value="13541" lower_limit="11890" upper_limit="15421"/>
                    <measurement group_id="O12" value="851" lower_limit="617" upper_limit="1174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8064" lower_limit="6645" upper_limit="9786"/>
                    <measurement group_id="O2" value="9707" lower_limit="8073" upper_limit="11672"/>
                    <measurement group_id="O3" value="10182" lower_limit="8395" upper_limit="12349"/>
                    <measurement group_id="O4" value="757" lower_limit="541" upper_limit="1060"/>
                    <measurement group_id="O5" value="11470" lower_limit="9660" upper_limit="13618"/>
                    <measurement group_id="O6" value="10131" lower_limit="8533" upper_limit="12028"/>
                    <measurement group_id="O7" value="11588" lower_limit="9686" upper_limit="13864"/>
                    <measurement group_id="O8" value="660" lower_limit="505" upper_limit="864"/>
                    <measurement group_id="O9" value="11302" lower_limit="10022" upper_limit="12746"/>
                    <measurement group_id="O10" value="13483" lower_limit="11909" upper_limit="15264"/>
                    <measurement group_id="O11" value="12158" lower_limit="10806" upper_limit="13680"/>
                    <measurement group_id="O12" value="791" lower_limit="596" upper_limit="1050"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4904" lower_limit="3848" upper_limit="6250"/>
                    <measurement group_id="O2" value="6584" lower_limit="5226" upper_limit="8294"/>
                    <measurement group_id="O3" value="5312" lower_limit="4171" upper_limit="6765"/>
                    <measurement group_id="O4" value="690" lower_limit="506" upper_limit="942"/>
                    <measurement group_id="O5" value="6908" lower_limit="5627" upper_limit="8480"/>
                    <measurement group_id="O6" value="6271" lower_limit="5087" upper_limit="7730"/>
                    <measurement group_id="O7" value="5824" lower_limit="4675" upper_limit="7256"/>
                    <measurement group_id="O8" value="763" lower_limit="596" upper_limit="978"/>
                    <measurement group_id="O9" value="6157" lower_limit="5018" upper_limit="7556"/>
                    <measurement group_id="O10" value="8651" lower_limit="7038" upper_limit="10635"/>
                    <measurement group_id="O11" value="7041" lower_limit="5765" upper_limit="8599"/>
                    <measurement group_id="O12" value="833" lower_limit="663" upper_limit="1046"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64" lower_limit="42" upper_limit="97"/>
                    <measurement group_id="O2" value="57" lower_limit="38" upper_limit="85"/>
                    <measurement group_id="O3" value="60" lower_limit="40" upper_limit="91"/>
                    <measurement group_id="O4" value="44" lower_limit="29" upper_limit="68"/>
                    <measurement group_id="O5" value="53" lower_limit="36" upper_limit="78"/>
                    <measurement group_id="O6" value="55" lower_limit="38" upper_limit="81"/>
                    <measurement group_id="O7" value="48" lower_limit="32" upper_limit="72"/>
                    <measurement group_id="O8" value="57" lower_limit="39" upper_limit="84"/>
                    <measurement group_id="O9" value="55" lower_limit="38" upper_limit="79"/>
                    <measurement group_id="O10" value="51" lower_limit="35" upper_limit="73"/>
                    <measurement group_id="O11" value="65" lower_limit="46" upper_limit="93"/>
                    <measurement group_id="O12" value="49" lower_limit="31" upper_limit="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64" lower_limit="56" upper_limit="73"/>
                    <measurement group_id="O2" value="55" lower_limit="49" upper_limit="62"/>
                    <measurement group_id="O3" value="59" lower_limit="52" upper_limit="66"/>
                    <measurement group_id="O4" value="43" lower_limit="27" upper_limit="67"/>
                    <measurement group_id="O5" value="50" lower_limit="43" upper_limit="59"/>
                    <measurement group_id="O6" value="47" lower_limit="41" upper_limit="55"/>
                    <measurement group_id="O7" value="46" lower_limit="39" upper_limit="53"/>
                    <measurement group_id="O8" value="51" lower_limit="34" upper_limit="75"/>
                    <measurement group_id="O9" value="59" lower_limit="51" upper_limit="69"/>
                    <measurement group_id="O10" value="47" lower_limit="41" upper_limit="54"/>
                    <measurement group_id="O11" value="57" lower_limit="50" upper_limit="66"/>
                    <measurement group_id="O12" value="55" lower_limit="34" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" lower_limit="53" upper_limit="71"/>
                    <measurement group_id="O2" value="53" lower_limit="47" upper_limit="61"/>
                    <measurement group_id="O3" value="55" lower_limit="48" upper_limit="64"/>
                    <measurement group_id="O4" value="42" lower_limit="28" upper_limit="65"/>
                    <measurement group_id="O5" value="49" lower_limit="43" upper_limit="56"/>
                    <measurement group_id="O6" value="46" lower_limit="40" upper_limit="53"/>
                    <measurement group_id="O7" value="44" lower_limit="38" upper_limit="51"/>
                    <measurement group_id="O8" value="46" lower_limit="31" upper_limit="68"/>
                    <measurement group_id="O9" value="60" lower_limit="51" upper_limit="71"/>
                    <measurement group_id="O10" value="43" lower_limit="36" upper_limit="50"/>
                    <measurement group_id="O11" value="51" lower_limit="43" upper_limit="59"/>
                    <measurement group_id="O12" value="52" lower_limit="32" upper_limit="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="51" upper_limit="73"/>
                    <measurement group_id="O2" value="55" lower_limit="46" upper_limit="65"/>
                    <measurement group_id="O3" value="58" lower_limit="49" upper_limit="69"/>
                    <measurement group_id="O4" value="40" lower_limit="26" upper_limit="60"/>
                    <measurement group_id="O5" value="49" lower_limit="40" upper_limit="59"/>
                    <measurement group_id="O6" value="54" lower_limit="44" upper_limit="66"/>
                    <measurement group_id="O7" value="47" lower_limit="39" upper_limit="58"/>
                    <measurement group_id="O8" value="60" lower_limit="44" upper_limit="82"/>
                    <measurement group_id="O9" value="54" lower_limit="43" upper_limit="67"/>
                    <measurement group_id="O10" value="45" lower_limit="36" upper_limit="56"/>
                    <measurement group_id="O11" value="53" lower_limit="43" upper_limit="66"/>
                    <measurement group_id="O12" value="49" lower_limit="31" upper_limit="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109" lower_limit="72" upper_limit="166"/>
                    <measurement group_id="O2" value="105" lower_limit="70" upper_limit="159"/>
                    <measurement group_id="O3" value="120" lower_limit="79" upper_limit="183"/>
                    <measurement group_id="O4" value="99" lower_limit="70" upper_limit="139"/>
                    <measurement group_id="O5" value="107" lower_limit="72" upper_limit="159"/>
                    <measurement group_id="O6" value="97" lower_limit="65" upper_limit="145"/>
                    <measurement group_id="O7" value="123" lower_limit="81" upper_limit="187"/>
                    <measurement group_id="O8" value="100" lower_limit="67" upper_limit="151"/>
                    <measurement group_id="O9" value="104" lower_limit="68" upper_limit="161"/>
                    <measurement group_id="O10" value="91" lower_limit="59" upper_limit="139"/>
                    <measurement group_id="O11" value="112" lower_limit="73" upper_limit="170"/>
                    <measurement group_id="O12" value="80" lower_limit="49" upper_limit="129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122" lower_limit="107" upper_limit="139"/>
                    <measurement group_id="O2" value="96" lower_limit="84" upper_limit="109"/>
                    <measurement group_id="O3" value="112" lower_limit="98" upper_limit="127"/>
                    <measurement group_id="O4" value="102" lower_limit="70" upper_limit="147"/>
                    <measurement group_id="O5" value="95" lower_limit="82" upper_limit="110"/>
                    <measurement group_id="O6" value="92" lower_limit="79" upper_limit="107"/>
                    <measurement group_id="O7" value="87" lower_limit="74" upper_limit="102"/>
                    <measurement group_id="O8" value="90" lower_limit="58" upper_limit="140"/>
                    <measurement group_id="O9" value="107" lower_limit="91" upper_limit="127"/>
                    <measurement group_id="O10" value="97" lower_limit="82" upper_limit="114"/>
                    <measurement group_id="O11" value="109" lower_limit="93" upper_limit="129"/>
                    <measurement group_id="O12" value="91" lower_limit="54" upper_limit="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="123" lower_limit="105" upper_limit="144"/>
                    <measurement group_id="O2" value="97" lower_limit="83" upper_limit="113"/>
                    <measurement group_id="O3" value="106" lower_limit="91" upper_limit="124"/>
                    <measurement group_id="O4" value="109" lower_limit="76" upper_limit="157"/>
                    <measurement group_id="O5" value="93" lower_limit="82" upper_limit="105"/>
                    <measurement group_id="O6" value="89" lower_limit="79" upper_limit="101"/>
                    <measurement group_id="O7" value="89" lower_limit="78" upper_limit="101"/>
                    <measurement group_id="O8" value="78" lower_limit="49" upper_limit="125"/>
                    <measurement group_id="O9" value="106" lower_limit="93" upper_limit="121"/>
                    <measurement group_id="O10" value="87" lower_limit="76" upper_limit="99"/>
                    <measurement group_id="O11" value="89" lower_limit="78" upper_limit="102"/>
                    <measurement group_id="O12" value="87" lower_limit="54" upper_limit="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106" lower_limit="87" upper_limit="128"/>
                    <measurement group_id="O2" value="94" lower_limit="78" upper_limit="112"/>
                    <measurement group_id="O3" value="101" lower_limit="84" upper_limit="122"/>
                    <measurement group_id="O4" value="98" lower_limit="70" upper_limit="139"/>
                    <measurement group_id="O5" value="99" lower_limit="85" upper_limit="116"/>
                    <measurement group_id="O6" value="112" lower_limit="95" upper_limit="131"/>
                    <measurement group_id="O7" value="93" lower_limit="79" upper_limit="111"/>
                    <measurement group_id="O8" value="101" lower_limit="72" upper_limit="141"/>
                    <measurement group_id="O9" value="102" lower_limit="88" upper_limit="119"/>
                    <measurement group_id="O10" value="94" lower_limit="80" upper_limit="109"/>
                    <measurement group_id="O11" value="98" lower_limit="84" upper_limit="113"/>
                    <measurement group_id="O12" value="87" lower_limit="53" upper_limit="141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="480" lower_limit="338" upper_limit="682"/>
                    <measurement group_id="O2" value="525" lower_limit="373" upper_limit="741"/>
                    <measurement group_id="O3" value="586" lower_limit="413" upper_limit="832"/>
                    <measurement group_id="O4" value="444" lower_limit="357" upper_limit="554"/>
                    <measurement group_id="O5" value="418" lower_limit="308" upper_limit="569"/>
                    <measurement group_id="O6" value="486" lower_limit="358" upper_limit="661"/>
                    <measurement group_id="O7" value="508" lower_limit="368" upper_limit="700"/>
                    <measurement group_id="O8" value="424" lower_limit="305" upper_limit="590"/>
                    <measurement group_id="O9" value="462" lower_limit="352" upper_limit="606"/>
                    <measurement group_id="O10" value="417" lower_limit="318" upper_limit="547"/>
                    <measurement group_id="O11" value="569" lower_limit="437" upper_limit="742"/>
                    <measurement group_id="O12" value="392" lower_limit="299" upper_limit="513"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="592" lower_limit="523" upper_limit="670"/>
                    <measurement group_id="O2" value="434" lower_limit="385" upper_limit="490"/>
                    <measurement group_id="O3" value="467" lower_limit="412" upper_limit="529"/>
                    <measurement group_id="O4" value="418" lower_limit="325" upper_limit="537"/>
                    <measurement group_id="O5" value="439" lower_limit="378" upper_limit="509"/>
                    <measurement group_id="O6" value="470" lower_limit="405" upper_limit="546"/>
                    <measurement group_id="O7" value="443" lower_limit="379" upper_limit="518"/>
                    <measurement group_id="O8" value="412" lower_limit="299" upper_limit="568"/>
                    <measurement group_id="O9" value="524" lower_limit="458" upper_limit="600"/>
                    <measurement group_id="O10" value="417" lower_limit="364" upper_limit="478"/>
                    <measurement group_id="O11" value="471" lower_limit="412" upper_limit="539"/>
                    <measurement group_id="O12" value="456" lower_limit="336" upper_limit="619"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="580" lower_limit="498" upper_limit="676"/>
                    <measurement group_id="O2" value="461" lower_limit="398" upper_limit="534"/>
                    <measurement group_id="O3" value="513" lower_limit="440" upper_limit="599"/>
                    <measurement group_id="O4" value="457" lower_limit="351" upper_limit="596"/>
                    <measurement group_id="O5" value="396" lower_limit="348" upper_limit="449"/>
                    <measurement group_id="O6" value="423" lower_limit="373" upper_limit="480"/>
                    <measurement group_id="O7" value="401" lower_limit="351" upper_limit="458"/>
                    <measurement group_id="O8" value="345" lower_limit="255" upper_limit="465"/>
                    <measurement group_id="O9" value="514" lower_limit="459" upper_limit="576"/>
                    <measurement group_id="O10" value="426" lower_limit="379" upper_limit="479"/>
                    <measurement group_id="O11" value="439" lower_limit="392" upper_limit="490"/>
                    <measurement group_id="O12" value="418" lower_limit="319" upper_limit="549"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="524" lower_limit="448" upper_limit="613"/>
                    <measurement group_id="O2" value="391" lower_limit="336" upper_limit="454"/>
                    <measurement group_id="O3" value="420" lower_limit="359" upper_limit="491"/>
                    <measurement group_id="O4" value="421" lower_limit="337" upper_limit="528"/>
                    <measurement group_id="O5" value="397" lower_limit="343" upper_limit="460"/>
                    <measurement group_id="O6" value="484" lower_limit="416" upper_limit="562"/>
                    <measurement group_id="O7" value="425" lower_limit="363" upper_limit="497"/>
                    <measurement group_id="O8" value="454" lower_limit="340" upper_limit="608"/>
                    <measurement group_id="O9" value="493" lower_limit="435" upper_limit="558"/>
                    <measurement group_id="O10" value="454" lower_limit="400" upper_limit="514"/>
                    <measurement group_id="O11" value="458" lower_limit="405" upper_limit="518"/>
                    <measurement group_id="O12" value="439" lower_limit="338" upper_limit="571"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With a ≥ 4-fold Increase in Serum Total Binding Antibody to Each of the RSV Proteins F, G and N</title>
        <description>Immunogenicity was measured in terms of the percentage of subjects with a ≥ 4-fold increase in serum total binding antibody to each of the RSV Proteins F, G and N from Day 1 (baseline) to all time points (Day 29 [28 days after the first dose], Day 57 [28 days after the second dose], and Day 181 [six months after the first dose]).</description>
        <time_frame>At Day 29, Day 57 and Day 181</time_frame>
        <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With a ≥ 4-fold Increase in Serum Total Binding Antibody to Each of the RSV Proteins F, G and N</title>
          <description>Immunogenicity was measured in terms of the percentage of subjects with a ≥ 4-fold increase in serum total binding antibody to each of the RSV Proteins F, G and N from Day 1 (baseline) to all time points (Day 29 [28 days after the first dose], Day 57 [28 days after the second dose], and Day 181 [six months after the first dose]).</description>
          <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="23"/>
                <count group_id="O10" value="23"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>RSV Protein F, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83" lower_limit="61.2" upper_limit="95.0"/>
                    <measurement group_id="O2" value="92" lower_limit="73.0" upper_limit="99.0"/>
                    <measurement group_id="O3" value="96" lower_limit="78.1" upper_limit="99.89"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O6" value="92" lower_limit="73.0" upper_limit="99.0"/>
                    <measurement group_id="O7" value="86" lower_limit="65.1" upper_limit="97.1"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O9" value="87" lower_limit="66.4" upper_limit="97.2"/>
                    <measurement group_id="O10" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O11" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" lower_limit="65.1" upper_limit="97.1"/>
                    <measurement group_id="O2" value="92" lower_limit="73.0" upper_limit="99.0"/>
                    <measurement group_id="O3" value="95" lower_limit="77.2" upper_limit="99.88"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O6" value="92" lower_limit="73.0" upper_limit="99.0"/>
                    <measurement group_id="O7" value="86" lower_limit="65.1" upper_limit="97.1"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="87" lower_limit="66.4" upper_limit="97.2"/>
                    <measurement group_id="O10" value="100" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O11" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73" lower_limit="49.8" upper_limit="89.3"/>
                    <measurement group_id="O2" value="79" lower_limit="57.8" upper_limit="92.9"/>
                    <measurement group_id="O3" value="68" lower_limit="45.1" upper_limit="86.1"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O5" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O6" value="73" lower_limit="49.8" upper_limit="89.3"/>
                    <measurement group_id="O7" value="75" lower_limit="50.9" upper_limit="91.3"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="73" lower_limit="49.8" upper_limit="89.3"/>
                    <measurement group_id="O10" value="100" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O11" value="83" lower_limit="61.2" upper_limit="95.0"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="16.8"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="16.8"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="14.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="16.8"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="15.4"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="14.8"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With Serum Total Binding Antibody Titers to Each of the RSV Proteins F, G, and N Greater Than the 3rd Quartile of Serum Total Binding Antibody Titers to RSV Protein F at Day 1</title>
        <description>Immunogenicity was measured in terms of the percentage of subjects at Day 29 (28 days after the first dose), Day 57 (28 days after the second dose) and Day 181 (six months after the first dose), with serum total binding antibody titers to each of the RSV proteins F, G, and N greater than the 3rd quartile of serum total binding antibody titers to RSV protein F at Day 1 (baseline).</description>
        <time_frame>At Day 29, Day 57 and Day 181</time_frame>
        <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Serum Total Binding Antibody Titers to Each of the RSV Proteins F, G, and N Greater Than the 3rd Quartile of Serum Total Binding Antibody Titers to RSV Protein F at Day 1</title>
          <description>Immunogenicity was measured in terms of the percentage of subjects at Day 29 (28 days after the first dose), Day 57 (28 days after the second dose) and Day 181 (six months after the first dose), with serum total binding antibody titers to each of the RSV proteins F, G, and N greater than the 3rd quartile of serum total binding antibody titers to RSV protein F at Day 1 (baseline).</description>
          <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="23"/>
                <count group_id="O10" value="23"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>RSV Protein F, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96" lower_limit="78.1" upper_limit="99.89"/>
                    <measurement group_id="O2" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O5" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O7" value="100" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="21" lower_limit="7.1" upper_limit="42.2"/>
                    <measurement group_id="O9" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O10" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O11" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O12" value="29" lower_limit="12.6" upper_limit="51.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="77.2" upper_limit="99.88"/>
                    <measurement group_id="O2" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O4" value="30" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O5" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O7" value="100" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="13" lower_limit="2.8" upper_limit="33.6"/>
                    <measurement group_id="O9" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O10" value="100" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O11" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O12" value="25" lower_limit="9.8" upper_limit="46.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O2" value="100" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O3" value="95" lower_limit="77.2" upper_limit="99.88"/>
                    <measurement group_id="O4" value="23" lower_limit="7.8" upper_limit="45.4"/>
                    <measurement group_id="O5" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O7" value="100" lower_limit="83.2" upper_limit="100.0"/>
                    <measurement group_id="O8" value="17" lower_limit="5.0" upper_limit="38.8"/>
                    <measurement group_id="O9" value="100" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O10" value="100" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O11" value="100" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O12" value="21" lower_limit="7.1" upper_limit="42.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O2" value="38" lower_limit="18.8" upper_limit="59.4"/>
                    <measurement group_id="O3" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O4" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O5" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O6" value="21" lower_limit="7.1" upper_limit="42.2"/>
                    <measurement group_id="O7" value="14" lower_limit="2.9" upper_limit="34.9"/>
                    <measurement group_id="O8" value="29" lower_limit="12.6" upper_limit="51.1"/>
                    <measurement group_id="O9" value="35" lower_limit="16.4" upper_limit="57.3"/>
                    <measurement group_id="O10" value="13" lower_limit="2.8" upper_limit="33.6"/>
                    <measurement group_id="O11" value="29" lower_limit="12.6" upper_limit="51.1"/>
                    <measurement group_id="O12" value="38" lower_limit="18.8" upper_limit="59.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="10.7" upper_limit="50.2"/>
                    <measurement group_id="O2" value="38" lower_limit="18.8" upper_limit="59.4"/>
                    <measurement group_id="O3" value="23" lower_limit="7.8" upper_limit="45.4"/>
                    <measurement group_id="O4" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O5" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O6" value="17" lower_limit="4.7" upper_limit="37.4"/>
                    <measurement group_id="O7" value="14" lower_limit="2.9" upper_limit="34.9"/>
                    <measurement group_id="O8" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O9" value="39" lower_limit="19.7" upper_limit="61.5"/>
                    <measurement group_id="O10" value="14" lower_limit="2.9" upper_limit="34.9"/>
                    <measurement group_id="O11" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O12" value="38" lower_limit="18.8" upper_limit="59.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" lower_limit="24.4" upper_limit="67.8"/>
                    <measurement group_id="O2" value="38" lower_limit="18.8" upper_limit="59.4"/>
                    <measurement group_id="O3" value="23" lower_limit="7.8" upper_limit="45.4"/>
                    <measurement group_id="O4" value="18" lower_limit="5.2" upper_limit="40.3"/>
                    <measurement group_id="O5" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O6" value="23" lower_limit="7.8" upper_limit="45.4"/>
                    <measurement group_id="O7" value="30" lower_limit="11.9" upper_limit="54.3"/>
                    <measurement group_id="O8" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O9" value="18" lower_limit="5.2" upper_limit="40.3"/>
                    <measurement group_id="O10" value="18" lower_limit="5.2" upper_limit="40.3"/>
                    <measurement group_id="O11" value="30" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O12" value="21" lower_limit="7.1" upper_limit="42.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O2" value="21" lower_limit="7.1" upper_limit="42.2"/>
                    <measurement group_id="O3" value="30" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O4" value="26" lower_limit="10.2" upper_limit="48.4"/>
                    <measurement group_id="O5" value="21" lower_limit="7.1" upper_limit="42.2"/>
                    <measurement group_id="O6" value="17" lower_limit="4.7" upper_limit="37.4"/>
                    <measurement group_id="O7" value="23" lower_limit="7.8" upper_limit="45.4"/>
                    <measurement group_id="O8" value="38" lower_limit="18.8" upper_limit="59.4"/>
                    <measurement group_id="O9" value="30" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O10" value="17" lower_limit="5.0" upper_limit="38.8"/>
                    <measurement group_id="O11" value="42" lower_limit="22.1" upper_limit="63.4"/>
                    <measurement group_id="O12" value="25" lower_limit="9.8" upper_limit="46.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36" lower_limit="17.2" upper_limit="59.3"/>
                    <measurement group_id="O2" value="17" lower_limit="4.7" upper_limit="37.4"/>
                    <measurement group_id="O3" value="27" lower_limit="10.7" upper_limit="50.2"/>
                    <measurement group_id="O4" value="39" lower_limit="19.7" upper_limit="61.5"/>
                    <measurement group_id="O5" value="21" lower_limit="7.1" upper_limit="42.2"/>
                    <measurement group_id="O6" value="17" lower_limit="4.7" upper_limit="37.4"/>
                    <measurement group_id="O7" value="27" lower_limit="10.7" upper_limit="50.2"/>
                    <measurement group_id="O8" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O9" value="35" lower_limit="16.4" upper_limit="57.3"/>
                    <measurement group_id="O10" value="23" lower_limit="7.8" upper_limit="45.4"/>
                    <measurement group_id="O11" value="21" lower_limit="7.1" upper_limit="42.2"/>
                    <measurement group_id="O12" value="25" lower_limit="9.8" upper_limit="46.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32" lower_limit="13.9" upper_limit="54.9"/>
                    <measurement group_id="O2" value="17" lower_limit="4.7" upper_limit="37.4"/>
                    <measurement group_id="O3" value="23" lower_limit="7.8" upper_limit="45.4"/>
                    <measurement group_id="O4" value="18" lower_limit="5.2" upper_limit="40.3"/>
                    <measurement group_id="O5" value="30" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O6" value="27" lower_limit="10.7" upper_limit="50.2"/>
                    <measurement group_id="O7" value="20" lower_limit="5.7" upper_limit="43.7"/>
                    <measurement group_id="O8" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O9" value="27" lower_limit="10.7" upper_limit="50.2"/>
                    <measurement group_id="O10" value="18" lower_limit="5.2" upper_limit="40.3"/>
                    <measurement group_id="O11" value="30" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O12" value="21" lower_limit="7.1" upper_limit="42.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39" lower_limit="19.7" upper_limit="61.5"/>
                    <measurement group_id="O2" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O3" value="35" lower_limit="16.4" upper_limit="57.3"/>
                    <measurement group_id="O4" value="9" lower_limit="1.1" upper_limit="28.0"/>
                    <measurement group_id="O5" value="21" lower_limit="7.1" upper_limit="42.2"/>
                    <measurement group_id="O6" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O7" value="23" lower_limit="7.8" upper_limit="45.4"/>
                    <measurement group_id="O8" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O9" value="26" lower_limit="10.2" upper_limit="48.4"/>
                    <measurement group_id="O10" value="17" lower_limit="5.0" upper_limit="38.8"/>
                    <measurement group_id="O11" value="29" lower_limit="12.6" upper_limit="51.1"/>
                    <measurement group_id="O12" value="33" lower_limit="15.6" upper_limit="55.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" lower_limit="24.4" upper_limit="67.8"/>
                    <measurement group_id="O2" value="33" lower_limit="15.6" upper_limit="55.3"/>
                    <measurement group_id="O3" value="50" lower_limit="28.2" upper_limit="71.8"/>
                    <measurement group_id="O4" value="17" lower_limit="5.0" upper_limit="38.8"/>
                    <measurement group_id="O5" value="8" lower_limit="1.0" upper_limit="27.0"/>
                    <measurement group_id="O6" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O7" value="27" lower_limit="10.7" upper_limit="50.2"/>
                    <measurement group_id="O8" value="9" lower_limit="1.1" upper_limit="28.0"/>
                    <measurement group_id="O9" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O10" value="14" lower_limit="2.9" upper_limit="34.9"/>
                    <measurement group_id="O11" value="21" lower_limit="7.1" upper_limit="42.2"/>
                    <measurement group_id="O12" value="17" lower_limit="4.7" upper_limit="37.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32" lower_limit="13.9" upper_limit="54.9"/>
                    <measurement group_id="O2" value="25" lower_limit="9.8" upper_limit="46.7"/>
                    <measurement group_id="O3" value="32" lower_limit="13.9" upper_limit="54.9"/>
                    <measurement group_id="O4" value="5" lower_limit="0.12" upper_limit="22.8"/>
                    <measurement group_id="O5" value="13" lower_limit="2.8" upper_limit="33.6"/>
                    <measurement group_id="O6" value="36" lower_limit="17.2" upper_limit="59.3"/>
                    <measurement group_id="O7" value="30" lower_limit="11.9" upper_limit="54.3"/>
                    <measurement group_id="O8" value="22" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O9" value="23" lower_limit="7.8" upper_limit="45.4"/>
                    <measurement group_id="O10" value="9" lower_limit="1.1" upper_limit="29.2"/>
                    <measurement group_id="O11" value="26" lower_limit="10.2" upper_limit="48.4"/>
                    <measurement group_id="O12" value="17" lower_limit="4.7" upper_limit="37.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio of RSV F Serum Nab Titers to Each of the RSV F Serum Total Binding Antibody Titers to RSV Proteins F, G and N</title>
        <description>Immunogenicity was measured in terms of the ratio of RSV F serum Nab titers to each of the RSV F serum total binding antibody titers to RSV proteins F, G and N at Days 1, 29, 57 and 181.</description>
        <time_frame>At Day 1, Day 29, Day 57 and Day 181</time_frame>
        <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
        <group_list>
          <group group_id="O1">
            <title>RSV F 45 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
          </group>
          <group group_id="O2">
            <title>RSV F 45 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O3">
            <title>RSV F 45 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 1 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
          </group>
          <group group_id="O5">
            <title>RSV F 90 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>RSV F 90 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O7">
            <title>RSV F 90 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O8">
            <title>Placebo 2 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
          </group>
          <group group_id="O9">
            <title>RSV F 135 No Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
          </group>
          <group group_id="O10">
            <title>RSV F 135 Alum Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
          </group>
          <group group_id="O11">
            <title>RSV F 135 MF59 Adj Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
          </group>
          <group group_id="O12">
            <title>Placebo 3 Group</title>
            <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Ratio of RSV F Serum Nab Titers to Each of the RSV F Serum Total Binding Antibody Titers to RSV Proteins F, G and N</title>
          <description>Immunogenicity was measured in terms of the ratio of RSV F serum Nab titers to each of the RSV F serum total binding antibody titers to RSV proteins F, G and N at Days 1, 29, 57 and 181.</description>
          <population>The analysis was based on the PPS, which included all subjects in the FAS Immunogenicity population who were not excluded due to reasons defined prior to unblinding or analysis and for whom immunogenicity data were available at Day 1, Day 29, Day 57 and Day 181.</population>
          <units>Adjusted Geometric Mean Ratio</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="24"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="24"/>
                <count group_id="O9" value="23"/>
                <count group_id="O10" value="23"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>RSV Protein F, Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.79" lower_limit="2.06" upper_limit="3.78"/>
                    <measurement group_id="O2" value="3.95" lower_limit="2.91" upper_limit="5.35"/>
                    <measurement group_id="O3" value="3.18" lower_limit="2.33" upper_limit="4.34"/>
                    <measurement group_id="O4" value="3.32" lower_limit="2.24" upper_limit="4.93"/>
                    <measurement group_id="O5" value="2.48" lower_limit="1.76" upper_limit="3.50"/>
                    <measurement group_id="O6" value="2.64" lower_limit="1.87" upper_limit="3.71"/>
                    <measurement group_id="O7" value="2.83" lower_limit="1.97" upper_limit="4.04"/>
                    <measurement group_id="O8" value="3.13" lower_limit="2.09" upper_limit="4.67"/>
                    <measurement group_id="O9" value="2.55" lower_limit="1.93" upper_limit="3.39"/>
                    <measurement group_id="O10" value="2.00" lower_limit="1.51" upper_limit="2.66"/>
                    <measurement group_id="O11" value="2.51" lower_limit="1.90" upper_limit="3.31"/>
                    <measurement group_id="O12" value="2.57" lower_limit="1.90" upper_limit="3.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="8.42" upper_limit="12"/>
                    <measurement group_id="O2" value="12" lower_limit="10" upper_limit="15"/>
                    <measurement group_id="O3" value="12" lower_limit="10" upper_limit="15"/>
                    <measurement group_id="O4" value="2.86" lower_limit="1.96" upper_limit="4.18"/>
                    <measurement group_id="O5" value="12" lower_limit="10" upper_limit="13"/>
                    <measurement group_id="O6" value="10" lower_limit="8.97" upper_limit="12"/>
                    <measurement group_id="O7" value="11" lower_limit="10" upper_limit="13"/>
                    <measurement group_id="O8" value="2.82" lower_limit="1.88" upper_limit="4.23"/>
                    <measurement group_id="O9" value="9.83" lower_limit="8.58" upper_limit="11"/>
                    <measurement group_id="O10" value="9.21" lower_limit="8.06" upper_limit="11"/>
                    <measurement group_id="O11" value="9.56" lower_limit="8.39" upper_limit="11"/>
                    <measurement group_id="O12" value="2.98" lower_limit="2.26" upper_limit="3.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.95" lower_limit="7.37" upper_limit="11"/>
                    <measurement group_id="O2" value="11" lower_limit="9.47" upper_limit="14"/>
                    <measurement group_id="O3" value="12" lower_limit="9.58" upper_limit="14"/>
                    <measurement group_id="O4" value="3.24" lower_limit="2.13" upper_limit="4.95"/>
                    <measurement group_id="O5" value="13" lower_limit="12" upper_limit="16"/>
                    <measurement group_id="O6" value="13" lower_limit="11" upper_limit="15"/>
                    <measurement group_id="O7" value="13" lower_limit="12" upper_limit="16"/>
                    <measurement group_id="O8" value="2.61" lower_limit="1.73" upper_limit="3.94"/>
                    <measurement group_id="O9" value="11" lower_limit="9.38" upper_limit="12"/>
                    <measurement group_id="O10" value="11" lower_limit="10" upper_limit="13"/>
                    <measurement group_id="O11" value="11" lower_limit="9.36" upper_limit="12"/>
                    <measurement group_id="O12" value="3.11" lower_limit="2.25" upper_limit="4.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein F, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.37" lower_limit="6.66" upper_limit="11"/>
                    <measurement group_id="O2" value="13" lower_limit="10" upper_limit="16"/>
                    <measurement group_id="O3" value="11" lower_limit="8.41" upper_limit="13"/>
                    <measurement group_id="O4" value="2.96" lower_limit="1.98" upper_limit="4.40"/>
                    <measurement group_id="O5" value="10" lower_limit="8.44" upper_limit="12"/>
                    <measurement group_id="O6" value="9.76" lower_limit="8.05" upper_limit="12"/>
                    <measurement group_id="O7" value="9.91" lower_limit="8.08" upper_limit="12"/>
                    <measurement group_id="O8" value="2.93" lower_limit="2.03" upper_limit="4.24"/>
                    <measurement group_id="O9" value="8.78" lower_limit="7.09" upper_limit="11"/>
                    <measurement group_id="O10" value="11" lower_limit="8.69" upper_limit="13"/>
                    <measurement group_id="O11" value="9.58" lower_limit="7.77" upper_limit="12"/>
                    <measurement group_id="O12" value="3.36" lower_limit="2.46" upper_limit="4.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" lower_limit="0.19" upper_limit="0.38"/>
                    <measurement group_id="O2" value="0.27" lower_limit="0.19" upper_limit="0.39"/>
                    <measurement group_id="O3" value="0.20" lower_limit="0.14" upper_limit="0.29"/>
                    <measurement group_id="O4" value="0.21" lower_limit="0.12" upper_limit="0.35"/>
                    <measurement group_id="O5" value="0.19" lower_limit="0.13" upper_limit="0.28"/>
                    <measurement group_id="O6" value="0.20" lower_limit="0.14" upper_limit="0.29"/>
                    <measurement group_id="O7" value="0.18" lower_limit="0.12" upper_limit="0.27"/>
                    <measurement group_id="O8" value="0.25" lower_limit="0.17" upper_limit="0.35"/>
                    <measurement group_id="O9" value="0.16" lower_limit="0.11" upper_limit="0.23"/>
                    <measurement group_id="O10" value="0.15" lower_limit="0.10" upper_limit="0.21"/>
                    <measurement group_id="O11" value="0.18" lower_limit="0.13" upper_limit="0.26"/>
                    <measurement group_id="O12" value="0.17" lower_limit="0.10" upper_limit="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.073" lower_limit="0.049" upper_limit="0.11"/>
                    <measurement group_id="O2" value="0.056" lower_limit="0.038" upper_limit="0.083"/>
                    <measurement group_id="O3" value="0.061" lower_limit="0.040" upper_limit="0.091"/>
                    <measurement group_id="O4" value="0.18" lower_limit="0.11" upper_limit="0.31"/>
                    <measurement group_id="O5" value="0.047" lower_limit="0.032" upper_limit="0.068"/>
                    <measurement group_id="O6" value="0.045" lower_limit="0.031" upper_limit="0.067"/>
                    <measurement group_id="O7" value="0.039" lower_limit="0.026" upper_limit="0.058"/>
                    <measurement group_id="O8" value="0.21" lower_limit="0.14" upper_limit="0.30"/>
                    <measurement group_id="O9" value="0.043" lower_limit="0.029" upper_limit="0.064"/>
                    <measurement group_id="O10" value="0.029" lower_limit="0.020" upper_limit="0.043"/>
                    <measurement group_id="O11" value="0.045" lower_limit="0.031" upper_limit="0.065"/>
                    <measurement group_id="O12" value="0.19" lower_limit="0.12" upper_limit="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.076" lower_limit="0.049" upper_limit="0.12"/>
                    <measurement group_id="O2" value="0.057" lower_limit="0.038" upper_limit="0.087"/>
                    <measurement group_id="O3" value="0.063" lower_limit="0.040" upper_limit="0.097"/>
                    <measurement group_id="O4" value="0.18" lower_limit="0.11" upper_limit="0.31"/>
                    <measurement group_id="O5" value="0.059" lower_limit="0.040" upper_limit="0.087"/>
                    <measurement group_id="O6" value="0.058" lower_limit="0.039" upper_limit="0.085"/>
                    <measurement group_id="O7" value="0.049" lower_limit="0.033" upper_limit="0.073"/>
                    <measurement group_id="O8" value="0.18" lower_limit="0.13" upper_limit="0.26"/>
                    <measurement group_id="O9" value="0.056" lower_limit="0.039" upper_limit="0.081"/>
                    <measurement group_id="O10" value="0.034" lower_limit="0.023" upper_limit="0.049"/>
                    <measurement group_id="O11" value="0.047" lower_limit="0.033" upper_limit="0.067"/>
                    <measurement group_id="O12" value="0.20" lower_limit="0.12" upper_limit="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Ga, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" lower_limit="0.078" upper_limit="0.18"/>
                    <measurement group_id="O2" value="0.095" lower_limit="0.064" upper_limit="0.14"/>
                    <measurement group_id="O3" value="0.11" lower_limit="0.075" upper_limit="0.17"/>
                    <measurement group_id="O4" value="0.17" lower_limit="0.10" upper_limit="0.29"/>
                    <measurement group_id="O5" value="0.076" lower_limit="0.052" upper_limit="0.11"/>
                    <measurement group_id="O6" value="0.097" lower_limit="0.066" upper_limit="0.14"/>
                    <measurement group_id="O7" value="0.065" lower_limit="0.043" upper_limit="0.098"/>
                    <measurement group_id="O8" value="0.23" lower_limit="0.17" upper_limit="0.32"/>
                    <measurement group_id="O9" value="0.074" lower_limit="0.050" upper_limit="0.11"/>
                    <measurement group_id="O10" value="0.054" lower_limit="0.036" upper_limit="0.080"/>
                    <measurement group_id="O11" value="0.078" lower_limit="0.053" upper_limit="0.12"/>
                    <measurement group_id="O12" value="0.20" lower_limit="0.12" upper_limit="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" lower_limit="0.31" upper_limit="0.67"/>
                    <measurement group_id="O2" value="0.48" lower_limit="0.33" upper_limit="0.71"/>
                    <measurement group_id="O3" value="0.43" lower_limit="0.29" upper_limit="0.64"/>
                    <measurement group_id="O4" value="0.46" lower_limit="0.30" upper_limit="0.71"/>
                    <measurement group_id="O5" value="0.38" lower_limit="0.26" upper_limit="0.57"/>
                    <measurement group_id="O6" value="0.35" lower_limit="0.24" upper_limit="0.52"/>
                    <measurement group_id="O7" value="0.46" lower_limit="0.30" upper_limit="0.69"/>
                    <measurement group_id="O8" value="0.43" lower_limit="0.29" upper_limit="0.65"/>
                    <measurement group_id="O9" value="0.30" lower_limit="0.20" upper_limit="0.46"/>
                    <measurement group_id="O10" value="0.26" lower_limit="0.17" upper_limit="0.40"/>
                    <measurement group_id="O11" value="0.31" lower_limit="0.21" upper_limit="0.47"/>
                    <measurement group_id="O12" value="0.27" lower_limit="0.16" upper_limit="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" lower_limit="0.087" upper_limit="0.19"/>
                    <measurement group_id="O2" value="0.099" lower_limit="0.067" upper_limit="0.15"/>
                    <measurement group_id="O3" value="0.12" lower_limit="0.082" upper_limit="0.18"/>
                    <measurement group_id="O4" value="0.43" lower_limit="0.27" upper_limit="0.69"/>
                    <measurement group_id="O5" value="0.086" lower_limit="0.059" upper_limit="0.12"/>
                    <measurement group_id="O6" value="0.076" lower_limit="0.053" upper_limit="0.11"/>
                    <measurement group_id="O7" value="0.090" lower_limit="0.061" upper_limit="0.13"/>
                    <measurement group_id="O8" value="0.37" lower_limit="0.25" upper_limit="0.56"/>
                    <measurement group_id="O9" value="0.079" lower_limit="0.051" upper_limit="0.12"/>
                    <measurement group_id="O10" value="0.061" lower_limit="0.039" upper_limit="0.094"/>
                    <measurement group_id="O11" value="0.083" lower_limit="0.054" upper_limit="0.13"/>
                    <measurement group_id="O12" value="0.32" lower_limit="0.19" upper_limit="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" lower_limit="0.089" upper_limit="0.22"/>
                    <measurement group_id="O2" value="0.11" lower_limit="0.069" upper_limit="0.16"/>
                    <measurement group_id="O3" value="0.13" lower_limit="0.082" upper_limit="0.20"/>
                    <measurement group_id="O4" value="0.47" lower_limit="0.29" upper_limit="0.76"/>
                    <measurement group_id="O5" value="0.11" lower_limit="0.074" upper_limit="0.16"/>
                    <measurement group_id="O6" value="0.098" lower_limit="0.067" upper_limit="0.14"/>
                    <measurement group_id="O7" value="0.12" lower_limit="0.080" upper_limit="0.18"/>
                    <measurement group_id="O8" value="0.31" lower_limit="0.20" upper_limit="0.48"/>
                    <measurement group_id="O9" value="0.10" lower_limit="0.067" upper_limit="0.16"/>
                    <measurement group_id="O10" value="0.068" lower_limit="0.044" upper_limit="0.10"/>
                    <measurement group_id="O11" value="0.081" lower_limit="0.054" upper_limit="0.12"/>
                    <measurement group_id="O12" value="0.34" lower_limit="0.20" upper_limit="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein Gb, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" lower_limit="0.12" upper_limit="0.29"/>
                    <measurement group_id="O2" value="0.17" lower_limit="0.11" upper_limit="0.25"/>
                    <measurement group_id="O3" value="0.21" lower_limit="0.14" upper_limit="0.32"/>
                    <measurement group_id="O4" value="0.42" lower_limit="0.26" upper_limit="0.67"/>
                    <measurement group_id="O5" value="0.16" lower_limit="0.11" upper_limit="0.23"/>
                    <measurement group_id="O6" value="0.17" lower_limit="0.12" upper_limit="0.25"/>
                    <measurement group_id="O7" value="0.15" lower_limit="0.10" upper_limit="0.23"/>
                    <measurement group_id="O8" value="0.39" lower_limit="0.28" upper_limit="0.55"/>
                    <measurement group_id="O9" value="0.15" lower_limit="0.098" upper_limit="0.23"/>
                    <measurement group_id="O10" value="0.11" lower_limit="0.072" upper_limit="0.17"/>
                    <measurement group_id="O11" value="0.14" lower_limit="0.090" upper_limit="0.21"/>
                    <measurement group_id="O12" value="0.35" lower_limit="0.21" upper_limit="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.99" lower_limit="1.44" upper_limit="2.74"/>
                    <measurement group_id="O2" value="2.40" lower_limit="1.75" upper_limit="3.31"/>
                    <measurement group_id="O3" value="2.10" lower_limit="1.52" upper_limit="2.92"/>
                    <measurement group_id="O4" value="2.07" lower_limit="1.33" upper_limit="3.22"/>
                    <measurement group_id="O5" value="1.51" lower_limit="1.11" upper_limit="2.04"/>
                    <measurement group_id="O6" value="1.76" lower_limit="1.30" upper_limit="2.38"/>
                    <measurement group_id="O7" value="1.88" lower_limit="1.37" upper_limit="2.58"/>
                    <measurement group_id="O8" value="1.82" lower_limit="1.20" upper_limit="2.77"/>
                    <measurement group_id="O9" value="1.34" lower_limit="1.04" upper_limit="1.71"/>
                    <measurement group_id="O10" value="1.21" lower_limit="0.94" upper_limit="1.56"/>
                    <measurement group_id="O11" value="1.59" lower_limit="1.24" upper_limit="2.03"/>
                    <measurement group_id="O12" value="1.34" lower_limit="0.96" upper_limit="1.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="24"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="23"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.59" lower_limit="0.42" upper_limit="0.82"/>
                    <measurement group_id="O2" value="0.47" lower_limit="0.34" upper_limit="0.65"/>
                    <measurement group_id="O3" value="0.52" lower_limit="0.38" upper_limit="0.73"/>
                    <measurement group_id="O4" value="1.77" lower_limit="1.12" upper_limit="2.79"/>
                    <measurement group_id="O5" value="0.36" lower_limit="0.27" upper_limit="0.50"/>
                    <measurement group_id="O6" value="0.44" lower_limit="0.32" upper_limit="0.60"/>
                    <measurement group_id="O7" value="0.44" lower_limit="0.32" upper_limit="0.60"/>
                    <measurement group_id="O8" value="1.70" lower_limit="1.15" upper_limit="2.52"/>
                    <measurement group_id="O9" value="0.36" lower_limit="0.27" upper_limit="0.48"/>
                    <measurement group_id="O10" value="0.26" lower_limit="0.20" upper_limit="0.35"/>
                    <measurement group_id="O11" value="0.39" lower_limit="0.30" upper_limit="0.51"/>
                    <measurement group_id="O12" value="1.60" lower_limit="1.15" upper_limit="2.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="23"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="24"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.62" lower_limit="0.43" upper_limit="0.89"/>
                    <measurement group_id="O2" value="0.53" lower_limit="0.37" upper_limit="0.75"/>
                    <measurement group_id="O3" value="0.63" lower_limit="0.44" upper_limit="0.90"/>
                    <measurement group_id="O4" value="1.96" lower_limit="1.23" upper_limit="3.11"/>
                    <measurement group_id="O5" value="0.43" lower_limit="0.32" upper_limit="0.57"/>
                    <measurement group_id="O6" value="0.53" lower_limit="0.39" upper_limit="0.71"/>
                    <measurement group_id="O7" value="0.51" lower_limit="0.37" upper_limit="0.70"/>
                    <measurement group_id="O8" value="1.36" lower_limit="0.95" upper_limit="1.96"/>
                    <measurement group_id="O9" value="0.46" lower_limit="0.36" upper_limit="0.60"/>
                    <measurement group_id="O10" value="0.33" lower_limit="0.26" upper_limit="0.43"/>
                    <measurement group_id="O11" value="0.43" lower_limit="0.33" upper_limit="0.55"/>
                    <measurement group_id="O12" value="1.65" lower_limit="1.12" upper_limit="2.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV Protein N, Day 181</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="22"/>
                    <count group_id="O7" value="20"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="22"/>
                    <count group_id="O10" value="22"/>
                    <count group_id="O11" value="23"/>
                    <count group_id="O12" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.87" lower_limit="0.61" upper_limit="1.24"/>
                    <measurement group_id="O2" value="0.73" lower_limit="0.52" upper_limit="1.02"/>
                    <measurement group_id="O3" value="0.89" lower_limit="0.62" upper_limit="1.26"/>
                    <measurement group_id="O4" value="1.80" lower_limit="1.13" upper_limit="2.88"/>
                    <measurement group_id="O5" value="0.54" lower_limit="0.39" upper_limit="0.74"/>
                    <measurement group_id="O6" value="0.81" lower_limit="0.58" upper_limit="1.12"/>
                    <measurement group_id="O7" value="0.73" lower_limit="0.52" upper_limit="1.03"/>
                    <measurement group_id="O8" value="1.75" lower_limit="1.20" upper_limit="2.54"/>
                    <measurement group_id="O9" value="0.65" lower_limit="0.51" upper_limit="0.84"/>
                    <measurement group_id="O10" value="0.54" lower_limit="0.42" upper_limit="0.70"/>
                    <measurement group_id="O11" value="0.69" lower_limit="0.54" upper_limit="0.89"/>
                    <measurement group_id="O12" value="1.77" lower_limit="1.25" upper_limit="2.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Solicited local and systemic symptoms: from Day 1 (6 hours) through Day 7 after each vaccination; Unsolicited AEs: from Day 1 through Day 28 after each vaccination; SAEs: from study start (Day 1) to study completion (Day 394).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>RSV F 45 No Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with no adjuvant.</description>
        </group>
        <group group_id="E2">
          <title>RSV F 45 Alum Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with aluminum hydroxide adjuvant.</description>
        </group>
        <group group_id="E3">
          <title>RSV F 45 MF59 Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the low dose RSV F subunit vaccine [45 μg], with MF59 adjuvant.</description>
        </group>
        <group group_id="E4">
          <title>Placebo 1 Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 1.</description>
        </group>
        <group group_id="E5">
          <title>RSV F 90 No Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with no adjuvant.</description>
        </group>
        <group group_id="E6">
          <title>RSV F 90 Alum Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with aluminum hydroxide adjuvant.</description>
        </group>
        <group group_id="E7">
          <title>RSV F 90 MF59 Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the medium dose RSV F subunit vaccine [90 μg], with MF59 adjuvant.</description>
        </group>
        <group group_id="E8">
          <title>Placebo 2 Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 2.</description>
        </group>
        <group group_id="E9">
          <title>RSV F 135 No Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with no adjuvant.</description>
        </group>
        <group group_id="E10">
          <title>RSV F 135 Alum Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with aluminum hydroxide adjuvant.</description>
        </group>
        <group group_id="E11">
          <title>RSV F 135 MF59 Adj Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of the high dose RSV F subunit vaccine [135 μg], with MF59 adjuvant.</description>
        </group>
        <group group_id="E12">
          <title>Placebo 3 Group</title>
          <description>Healthy female and male subjects, 18 to 45 years of age, who received two doses of an intramuscular injection of saline solution. Subjects were enrolled in a stepwise dosage escalation manner into one of the three cohorts (Cohort 1: low dosage of RSV F subunit vaccine [45 μg], Cohort 2: middle dosage of RSV F subunit vaccine [90 μg], and Cohort 3: high dosage of RSV F subunit vaccine [135 μg]). This placebo group belongs to Cohort 3.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 20.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Basedow's disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Cartilage injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 20.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="24"/>
                <counts group_id="E5" subjects_affected="24" subjects_at_risk="24"/>
                <counts group_id="E6" subjects_affected="24" subjects_at_risk="24"/>
                <counts group_id="E7" subjects_affected="24" subjects_at_risk="24"/>
                <counts group_id="E8" subjects_affected="21" subjects_at_risk="24"/>
                <counts group_id="E9" subjects_affected="23" subjects_at_risk="24"/>
                <counts group_id="E10" subjects_affected="24" subjects_at_risk="24"/>
                <counts group_id="E11" subjects_affected="23" subjects_at_risk="24"/>
                <counts group_id="E12" subjects_affected="22" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" events="9" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E5" events="7" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E6" events="4" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E8" events="7" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E10" events="8" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E11" events="9" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E4" events="7" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E5" events="8" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E6" events="9" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E7" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E8" events="13" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E9" events="8" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E10" events="8" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E11" events="9" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E12" events="7" subjects_affected="5" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="5" subjects_affected="3" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Tooth disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Gingival pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" events="27" subjects_affected="18" subjects_at_risk="24"/>
                <counts group_id="E2" events="32" subjects_affected="21" subjects_at_risk="24"/>
                <counts group_id="E3" events="32" subjects_affected="19" subjects_at_risk="24"/>
                <counts group_id="E4" events="9" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E5" events="27" subjects_affected="17" subjects_at_risk="24"/>
                <counts group_id="E6" events="32" subjects_affected="21" subjects_at_risk="24"/>
                <counts group_id="E7" events="36" subjects_affected="22" subjects_at_risk="24"/>
                <counts group_id="E8" events="5" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E9" events="30" subjects_affected="20" subjects_at_risk="24"/>
                <counts group_id="E10" events="33" subjects_affected="23" subjects_at_risk="24"/>
                <counts group_id="E11" events="32" subjects_affected="19" subjects_at_risk="24"/>
                <counts group_id="E12" events="12" subjects_affected="8" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="13" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E2" events="14" subjects_affected="10" subjects_at_risk="24"/>
                <counts group_id="E3" events="20" subjects_affected="13" subjects_at_risk="24"/>
                <counts group_id="E4" events="24" subjects_affected="13" subjects_at_risk="24"/>
                <counts group_id="E5" events="23" subjects_affected="10" subjects_at_risk="24"/>
                <counts group_id="E6" events="16" subjects_affected="14" subjects_at_risk="24"/>
                <counts group_id="E7" events="16" subjects_affected="12" subjects_at_risk="24"/>
                <counts group_id="E8" events="22" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E9" events="13" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E10" events="16" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E11" events="21" subjects_affected="12" subjects_at_risk="24"/>
                <counts group_id="E12" events="16" subjects_affected="9" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Injection site induration</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="7" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E6" events="10" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E7" events="8" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="9" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E10" events="13" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E11" events="11" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E12" events="4" subjects_affected="3" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E5" events="5" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E6" events="10" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E7" events="8" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E9" events="6" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E10" events="11" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E11" events="5" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E12" events="7" subjects_affected="5" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E3" events="5" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E6" events="3" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="7" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="11" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E10" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E11" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E6" events="5" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E8" events="3" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E9" events="6" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E10" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E11" events="5" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E9" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E10" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Injection site haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Hangover</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="16" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="24"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="24"/>
                <counts group_id="E4" events="15" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E5" events="19" subjects_affected="10" subjects_at_risk="24"/>
                <counts group_id="E6" events="15" subjects_affected="13" subjects_at_risk="24"/>
                <counts group_id="E7" events="12" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E8" events="13" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E9" events="10" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E10" events="11" subjects_affected="10" subjects_at_risk="24"/>
                <counts group_id="E11" events="8" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E12" events="12" subjects_affected="9" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E4" events="8" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E5" events="10" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E6" events="7" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E7" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E8" events="14" subjects_affected="12" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E11" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E4" events="3" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E4" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E8" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E9" events="5" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E11" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Tinea pedis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E8" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E11" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="3" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E9" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E10" events="6" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E11" events="6" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E3" events="7" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E6" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E7" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E8" events="3" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E9" events="5" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E10" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E11" events="8" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E11" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="14" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E2" events="26" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E3" events="10" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E4" events="23" subjects_affected="14" subjects_at_risk="24"/>
                <counts group_id="E5" events="31" subjects_affected="14" subjects_at_risk="24"/>
                <counts group_id="E6" events="21" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E7" events="23" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E8" events="24" subjects_affected="12" subjects_at_risk="24"/>
                <counts group_id="E9" events="19" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E10" events="21" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E11" events="21" subjects_affected="13" subjects_at_risk="24"/>
                <counts group_id="E12" events="13" subjects_affected="10" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="4" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E11" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="3" subjects_affected="2" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="25" subjects_affected="12" subjects_at_risk="24"/>
                <counts group_id="E2" events="31" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E3" events="24" subjects_affected="12" subjects_at_risk="24"/>
                <counts group_id="E4" events="21" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E5" events="14" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E6" events="15" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E7" events="13" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E8" events="14" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E9" events="12" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E10" events="21" subjects_affected="10" subjects_at_risk="24"/>
                <counts group_id="E11" events="22" subjects_affected="12" subjects_at_risk="24"/>
                <counts group_id="E12" events="17" subjects_affected="11" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="15" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E2" events="10" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E3" events="15" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E4" events="10" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E5" events="10" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E6" events="11" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E7" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E8" events="3" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E9" events="7" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E10" events="17" subjects_affected="9" subjects_at_risk="24"/>
                <counts group_id="E11" events="14" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E12" events="12" subjects_affected="10" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E8" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E10" events="6" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E11" events="7" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E12" events="7" subjects_affected="5" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>GSK Response Center</name_or_title>
      <organization>GlaxoSmithKline</organization>
      <phone>866-435-7343</phone>
      <email>kt144805@gsk.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

